Genentech, Inc.:戦略・SWOT・企業財務分析

◆英語タイトル:Genentech, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015634
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Genentech, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genentech, Inc. (Genentech or ‘the company’), a wholly-owned subsidiary of the Roche Group, is a leading biotechnology company. The company is engaged in the discovery, development, manufacture and commercialization of medicines to treat patients with serious or life-threatening medical conditions. It is headquartered in South San Francisco, California.

Scope

- Detailed information on Genentech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
- Intelligence on Genentech, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genentech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genentech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genentech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genentech, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Genentech, Inc.: Company Overview
Genentech, Inc.: Overview and Key Facts
Genentech, Inc.: Overview
Genentech, Inc.: Key Facts
Genentech, Inc.: Key Employees
Genentech, Inc.: Key Employee Biographies
Genentech, Inc.: Major Products and Services
Genentech, Inc.: Company History
Genentech, Inc.: Management Statement
Genentech, Inc.: Locations and Subsidiaries
Genentech, Inc.: Key Competitors
Genentech, Inc.: Company Analysis
Genentech, Inc.: Business Description
Genentech, Inc.: SWOT Analysis
Genentech, Inc.: SWOT Overview
Genentech, Inc.: Strengths
Genentech, Inc.: Weaknesses
Genentech, Inc.: Opportunities
Genentech, Inc.: Threats
Genentech, Inc.: Corporate Financial Deals Activity
Genentech, Inc.: Financial Deals Overview
Genentech, Inc.: Targets and Partners
Genentech, Inc.: Top Deals 2013 – 2017YTD*
Genentech, Inc.: Mergers and Acquisitions
Genentech, Inc.: Partnership
Genentech, Inc.: Recent Developments
Genentech, Inc.: News and Events Summary
Genentech, Inc.: Contracts
Genentech, Inc.: Market Developments
Genentech, Inc.: Regulatory and Legal Events
Genentech, Inc.: Research & Development
Genentech, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Genentech, Inc.: Key Facts
Table 2: Genentech, Inc.: Key Employees
Table 3: Genentech, Inc.: Locations and Subsidiaries
Table 4: Genentech, Inc.: Key Competitors
Table 5: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genentech, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Genentech, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Genentech, Inc.: Targets and Partners
Table 9: Genentech, Inc.: Top Deals 2013 - 2017YTD*
Table 10: Genentech, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Genentech, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Genentech, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: Genentech, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: Genentech, Inc.: News and Events Summary
Table 15: Genentech, Inc.: Contracts
Table 16: Genentech, Inc.: Market Developments
Table 17: Genentech, Inc.: Regulatory and Legal Events
Table 18: Genentech, Inc.: Research & Development
Table 19: Genentech, Inc.: Strategy and Operations

★海外企業調査レポート[Genentech, Inc.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bank Rossiya:企業の戦略・SWOT・財務分析
    Bank Rossiya - Strategy, SWOT and Corporate Finance Report Summary Bank Rossiya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Asia Hotel Public Company Limited:企業の戦略・SWOT・財務情報
    Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cofidis Participations S.A.:企業の戦略・SWOT・財務分析
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Wistron Corporation
    Wistron Corporation - Strategy, SWOT and Corporate Finance Report Summary Wistron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Baron Oil Plc (BOIL):企業の財務・戦略的SWOT分析
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • New Zealand Post Ltd:企業の戦略的SWOT分析
    New Zealand Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fujikura Ltd.:企業の戦略・SWOT・財務分析
    Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • HanAll Biopharma Co Ltd (009420):企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops gene expression platform for production of industrial enzymes and other proteins. The company utilizes C1 technology, an expression system based on the fungus Myceliophthora thermophila, to discover and manufacture bi …
  • FirstRand Private Bank:企業の戦略・SWOT・財務情報
    FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report Summary FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Storebrand ASA:戦略・SWOT・企業財務分析
    Storebrand ASA - Strategy, SWOT and Corporate Finance Report Summary Storebrand ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China Shenhua Energy Co Ltd:企業の戦略・SWOT・財務情報
    China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Trinity Mirror plc:企業の戦略・SWOT・財務情報
    Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report Summary Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KEC International Ltd:企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canada Bread Company, Limited:企業の戦略・SWOT・財務情報
    Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vivendi S.A. (VIV):企業の財務・戦略的SWOT分析
    Vivendi S.A. (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn), formerly RexRay Corp, is a biotechnology company. It develops and commercializes monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. It is investigating Leronlimab (PRO 140), a fully humanized IgG4 monoclonal antibody directed agai …
  • Turisthotel d.d.:企業の戦略・SWOT・財務情報
    Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report Summary Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆